Thermo Fisher Scientific Inc. TMO
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.06B | 4.06B | 3.26B | 10.11B | 3.55B |
| Total Receivables | 11.32B | 11.14B | 10.89B | 10.57B | 10.53B |
| Inventory | 5.64B | 5.63B | 5.50B | 5.43B | 5.75B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.60B | 2.54B | 2.68B | 2.61B | 2.47B |
| Total Current Assets | 25.62B | 23.37B | 22.32B | 28.71B | 22.30B |
|
|
|||||
| Total Current Assets | 25.62B | 23.37B | 22.32B | 28.71B | 22.30B |
| Net Property, Plant & Equipment | 10.58B | 10.76B | 10.66B | 12.01B | 10.18B |
| Long-term Investments | 54.26B | 54.83B | 55.19B | 49.36B | 49.29B |
| Goodwill | 54.26B | 54.83B | 55.19B | 49.36B | 49.29B |
| Total Other Intangibles | 18.08B | 18.61B | 19.15B | 15.84B | 16.24B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.70B | 5.62B | 5.97B | 3.99B | 5.02B |
| Total Assets | 114.23B | 113.17B | 113.28B | 110.34B | 103.02B |
|
|
|||||
| Total Accounts Payable | 3.09B | 3.27B | 3.34B | 3.62B | 3.12B |
| Total Accrued Expenses | 5.80B | 5.44B | 5.19B | 4.98B | 5.01B |
| Short-term Debt | -- | -- | -- | -- | 500.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.26B | 3.37B | 3.09B | 3.81B | 3.32B |
| Total Finance Division Other Current Liabilities | 3.02B | 2.99B | 2.99B | 2.78B | 2.94B |
| Total Other Current Liabilities | 3.02B | 2.99B | 2.99B | 2.78B | 2.94B |
| Total Current Liabilities | 14.17B | 15.07B | 14.62B | 15.19B | 14.89B |
|
|
|||||
| Total Current Liabilities | 14.17B | 15.07B | 14.62B | 15.19B | 14.89B |
| Long-Term Debt | 38.85B | 38.92B | 39.86B | 35.65B | 31.66B |
| Short-term Debt | -- | -- | -- | -- | 500.00M |
| Capital Leases | 262.00M | 264.00M | 213.00M | 1.40B | 196.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.06B | 6.12B | 6.53B | 4.57B | 5.12B |
| Total Liabilities | 59.34B | 60.37B | 61.22B | 56.81B | 51.87B |
|
|
|||||
| Common Stock & APIC | 19.69B | 19.32B | 19.16B | 19.01B | 18.78B |
| Retained Earnings | 63.74B | 62.19B | 60.63B | 59.16B | 57.35B |
| Treasury Stock & Other | -28.67B | -28.83B | -27.86B | -24.76B | -25.11B |
| Total Common Equity | 54.76B | 52.68B | 51.93B | 53.41B | 51.02B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 54.76B | 52.68B | 51.93B | 53.41B | 51.02B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 134.00M | 128.00M | 128.00M | 129.00M | 136.00M |
| Total Equity | 54.90B | 52.81B | 52.06B | 53.54B | 51.15B |
|
|
|||||